de Bari O, Wang TY, Liu M, Chang-Nyol P, Portincasa P, Q-H Wang D

Language: English
References: 179
Page: 728-745
PDF size: 228.13 Kb.

ABSTRACT

Epidemiological and clinical studies have found that gallstone prevalence is twice as high in women as in men at all ages in every population studied. Hormonal changes occurring during pregnancy put women at higher risk. The incidence rates of biliary sludge (a precursor to gallstones) and gallstones are up to 30 and 12%, respectively, during pregnancy and postpartum, and 1-3% of pregnant women undergo cholecystectomy due to clinical symptoms or complications within the first year postpartum. Increased estrogen levels during pregnancy induce significant metabolic changes in the hepatobiliary system, including the formation of cholesterol-supersaturated bile and sluggish gallbladder motility, two factors enhancing cholelithogenesis. The therapeutic approaches are conservative during pregnancy because of the controversial frequency of biliary disorders. In the majority of pregnant women, biliary sludge and gallstones tend to dissolve spontaneously after parturition. In some situations, however, the conditions persist and require costly therapeutic interventions. When necessary, invasive procedures such as laparoscopic cholecystectomy are relatively well tolerated, preferably during the second trimester of pregnancy or postpartum. Although laparoscopic operation is recommended for its safety, the use of drugs such as ursodeoxycholic acid (UDCA) and the novel lipid-lowering compound, ezetimibe would also be considered. In this paper, we systematically review the incidence and natural history of pregnancy-related biliary sludge and gallstone formation and carefully discuss the molecular mechanisms underlying the lithogenic effect of estrogen on gallstone formation during pregnancy. We also summarize recent progress in the necessary strategies recommended for the prevention and the treatment of gallstones in pregnant women.

REFERENCES

1. Everson GT, McKinley C, Kern F, Jr. Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J Clin Invest 1991; 87: 237-46.

2. Boston Collaborative Drug Surveillance Programme. Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumours. Lancet 1973; 1: 1399-404.

3. The Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. N Engl J Med 1974; 290: 15-9.

4. The Coronary Drug Project Research Group. Gallbladder disease as a side effect of drugs influencing lipid metabolism. Experience in the Coronary Drug Project. N Engl J Med 1977; 296: 1185-90.

5. Cirillo DJ, Wallace RB, Rodabough RJ, Greenland P, LaCroix AZ, Limacher MC, Larson JC. Effect of estrogen therapy on gallbladder disease. JAMA 2005; 293: 330-9.

6. Honore LH. Increased incidence of symptomatic cholesterol cholelithiasis in perimenopausal women receiving estrogen replacement therapy: a retrospective study. J Reprod Med 1980; 25: 187-90.

7. Thijs C, Knipschild P. Oral contraceptives and the risk of gallbladder disease: a meta-analysis. Am J Public Health 1993; 83: 1113-20.

8. Henriksson P, Einarsson K, Eriksson A, Kelter U, Angelin B. Estrogen-induced gallstone formation in males. Relation to changes in serum and biliary lipids during hormonal treatment of prostatic carcinoma. J Clin Invest 1989; 84: 811-6.

9. Grodstein F, Colditz GA, Stampfer MJ. Postmenopausal hormone use and cholecystectomy in a large prospective study. Obstet Gynecol 1994; 83: 5-11.

10. Wang HH, Liu M, Clegg DJ, Portincasa P, Wang DQ. New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation. Biochim Biophys Acta 2009; 1791: 1037-47.

11. Angelin B, Olivecrona H, Reihner E, Rudling M, Stahlberg D, Eriksson M, Ewerth S, et al. Hepatic cholesterol metabolism in estrogen-treated men. Gastroenterology 1992; 103: 1657-63.

12. Novacek G. Gender and gallstone disease. Wien Med Wochenschr 2006; 156: 527-33.

13. Diehl AK. Epidemiology and natural history of gallstone disease. Gastroenterol Clin North Am 1991; 20: 1-19.

14. Barbara L, Sama C, Morselli Labate AM, Taroni F, Rusticali AG, Festi D, Sapio C, et al. A population study on the prevalence of gallstone disease: the Sirmione Study. Hepatology 1987; 7: 913-7.

15. Layde PM, Vessey MP, Yeates D. Risk factors for gallbladder disease: a cohort study of young women attending family planning clinics. J Epidemiol Community Health 1982; 36: 274-8.

16. Friedman GD, Kannel WB, Dawber TR. The epidemiology of gallbladder disease: observations in the Framingham Study. J Chronic Dis 1966; 19: 273-92.

17. Scragg RK, McMichael AJ, Seamark RF. Oral contraceptives, pregnancy, and endogenous oestrogen in gall stone disease— a case-control study. Br Med J 1984; 288: 1795-9.

18. Dhiman RK, Chawla YK. Is there a link between oestrogen therapy and gallbladder disease? Expert Opin Drug Saf 2006; 5: 117-29.

19. Kern F Jr., Everson GT, DeMark B, McKinley C, Showalter R, Braverman DZ, Szczepanik-Van Leeuwen P, et al. Biliary lipids, bile acids, and gallbladder function in the human female: effects of contraceptive steroids. J Lab Clin Med 1982; 99: 798-805.

20. Maringhini A, Ciambra M, Baccelliere P, Raimondo M, Orlando A, Tine F, Grasso R, et al. Biliary sludge and gallstones in pregnancy: incidence, risk factors, and natural history. Ann Intern Med 1993; 119: 116-20.

21. Bolukbas FF, Bolukbas C, Horoz M, Ince AT, Uzunkoy A, Ozturk A, Aka N, et al. Risk factors associated with gallstone and biliary sludge formation during pregnancy. J Gastroenterol Hepatol 2006; 21: 1150-3.

22. Maringhini A, Marceno MP, Lanzarone F, Caltagirone M, Fusco G, Di Cuonzo G, Cittadini E, et al. Sludge and stones in gallbladder after pregnancy. Prevalence and risk factors. J Hepatol 1987; 5: 218-23.

23. Valdivieso V, Covarrubias C, Siegel F, Cruz F. Pregnancy and cholelithiasis: pathogenesis and natural course of gallstones diagnosed in early puerperium. Hepatology 1993; 17: 1-4.

24. Basso L, McCollum PT, Darling MR, Tocchi A, Tanner WA. A study of cholelithiasis during pregnancy and its relationship with age, parity, menarche, breast-feeding, dysmenorrhea, oral contraception and a maternal history of cholelithiasis. Surg Gynecol Obstet 1992; 175: 41-6.

25. Stauffer RA, Adams A, Wygal J, Lavery JP. Gallbladder disease in pregnancy. Am J Obstet Gynecol 1982; 144: 661-4.

26. Ros E, Navarro S, Bru C, Garcia-Puges A, Valderrama R. Occult microlithiasis in ‘idiopathic’ acute pancreatitis: prevention of relapses by cholecystectomy or ursodeoxycholic acid therapy. Gastroenterology 1991; 101: 1701-9.

27. Ko CW, Beresford SA, Schulte SJ, Matsumoto AM, Lee SP. Incidence, natural history, and risk factors for biliary sludge and stones during pregnancy. Hepatology 2005; 41: 359-65.

28. Glasinovic JC, Mege R, Ferreiro O, Rodríguez N, Marinovic I, Villarroel L, Vela P. Cholelithiasis in Chilean female population. Prevalence and associated risk factors. Gastroenterology 1986; 96: A601.

29. Van Bodegraven AA, Bohmer CJ, Manoliu RA, Paalman E, Van der Klis AH, Roex AJ, Kruishoop AM, et al. Gallbladder contents and fasting gallbladder volumes during and after pregnancy. Scand J Gastroenterol 1998; 33: 993-7.

30. Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology 1999; 117: 632-9.

31. Thijs C, Knipschild P, Leffers P. Pregnancy and gallstone disease: an empiric demonstration of the importance of specification of risk periods. Am J Epidemiol 1991; 134: 186-95.

32. The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO).The epidemiology of gallstone disease in Rome, Italy. Part II. Factors associated with the disease. Hepatology 1988; 8: 907-13.

33. Stampfer MJ, Maclure KM, Colditz GA, Manson JE, Willett WC. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr 1992; 55: 652-8. de Bari O, et al. , 2014; 13 (6): 728-745 742

34. Lindseth G, Bird-Baker MY. Risk factors for cholelithiasis in pregnancy. Res Nurs Health 2004; 27: 382-91.

35. Ko CW. Risk factors for gallstone-related hospitalization during pregnancy and the postpartum. Am J Gastroenterol 2006; 101: 2263-8.

36. Lydon-Rochelle M, Holt VL, Martin DP, Easterling TR. Association between method of delivery and maternal rehospitalization. JAMA 2000; 283: 2411-6.

37. Printen KJ, Ott RA. Cholecystectomy during pregnancy. Am Surg 1978; 44: 432-4.

38. Carpenter MW. Gestational diabetes, pregnancy hypertension, and late vascular disease. Diabetes Care 2007; 30 (Suppl. 2): S246-S250.

39. Valdiviezo C, Garovic VD, Ouyang P. Preeclampsia and hypertensive disease in pregnancy: their contributions to cardiovascular risk. Clin Cardiol 2012; 35: 160-5.

40. Bennion LJ, Ginsberg RL, Gernick MB, Bennett PH. Effects of oral contraceptives on the gallbladder bile of normal women. N Engl J Med 1976; 294: 189-92.

41. Lynn J, Williams L, O’Brien J, Wittenberg J, Egdahl RH. Effects of estrogen upon bile: implications with respect to gallstone formation. Ann Surg 1973; 178: 514-24.

42. Pertsemlidis D, Panveliwalla D, Ahrens EH, Jr. Effects of clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetics in man. Gastroenterology 1974; 66: 565-73.

43. Kern F Jr., Everson GT. Contraceptive steroids increase cholesterol in bile: mechanisms of action. J Lipid Res 1987; 28: 828-39.

44. Bennion LJ, Mott DM, Howard BV. Oral contraceptives raise the cholesterol saturation of bile by increasing biliary cholesterol secretion. Metabolism 1980; 29: 18-22.

45. van der Werf SD, van Berge Henegouwen GP, Ruben AT, Palsma DM. Biliary lipids, bile acid metabolism, gallbladder motor function and small intestinal transit during ingestion of a sub-fifty oral contraceptive. J Hepatol 1987; 4: 318-26.

46. Heuman R, Larsson-Cohn U, Hammar M, Tiselius HG. Effects of postmenopausal ethinylestradiol treatment on gallbladder bile. Maturitas 1980; 2: 69-72.

47. Anderson A, James OF, MacDonald HS, Snowball S, Taylor W. The effect of ethynyl oestradiol on biliary lipid composition in young men. Eur J Clin Invest 1980; 10: 77-80.

48. Vazquez MC, Rigotti A, Zanlungo S. Molecular mechanisms underlying the link between nuclear receptor function and cholesterol gallstone formation. J Lipids 2012; 2012: 547643.

49. Portincasa P, Di Ciaula A, Wang HH, Palasciano G, van Erpecum KJ, Moschetta A, Wang DQ. Coordinate regulation of gallbladder motor function in the gut-liver axis. Hepatology 2008; 47: 2112-26.

50. Everson GT. Pregnancy and gallstones. Hepatology 1993; 17: 159-61.

51. Everson GT, McKinley C, Lawson M, Johnson M, Kern F, Jr. Gallbladder function in the human female: effect of the ovulatory cycle, pregnancy, and contraceptive steroids. Gastroenterology 1982; 82: 711-9.

52. Braverman DZ, Johnson ML, Kern F, Jr. Effects of pregnancy and contraceptive steroids on gallbladder function. N Engl J Med 1980; 302: 362-4.

53. Wang HH, Afdhal NH, Wang DQ. Estrogen receptor alpha, but not beta, plays a major role in 17beta-estradiol-induced murine cholesterol gallstones. Gastroenterology 2004; 127: 239-49.

54. Wang HH, Portincasa P, Wang DQ. Molecular pathophysiology and physical chemistry of cholesterol gallstones. Front Biosci 2008; 13: 401-23.

55. Silverthorn DU. Human Physiology: An Integrated Approach. 6th ed. Glenview, IL: Pearson Education, Inc.; 2013.

56. Speroff L GR, Kase NG. Clinical gynecologic endocrinology and infertility. 6th Ed. Baltimore; 1999.

57. Ferin M JR, Warren M. The menstrual cycle. In Physiology, Reproductive Disorders, and Infertility. New York; 1993.

58. Senie RT, Tenser SM. The timing of breast cancer surgery during the menstrual cycle. Oncology 1997; 11: 1509-17.

59. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993; 15: 17-35.

60. Chikazawa K, Araki S, Tamada T. Morphological and endocrinological studies on follicular development during the human menstrual cycle. J Clin Endocrinol Metab 1986; 62: 305-13.

61. Tsimoyiannis EC, Antoniou NC, Tsaboulas C, Papanikolaou N. Cholelithiasis during pregnancy and lactation. Prospective study. Eur J Surg 1994; 160: 627-31.

62. Hay JE. Liver disease in pregnancy. Hepatology 2008; 47: 1067-76.

63. Mendez-Sanchez N, Chavez-Tapia NC, Uribe M. Pregnancy and gallbladder disease. Ann Hepatol 2006; 5: 227-30.

64. Scott LD. Gallstone disease and pancreatitis in pregnancy. Gastroenterol Clin North Am 1992; 21: 803-15.

65. Trotman BW, Soloway RD. Pigment vs cholesterol cholelithiasis: clinical and epidemiological aspects. Am J Dig Dis 1975; 20: 735-40.

66. Neil Bajwa RB, Ambrish Ghumman, Agrawal R. M. . The Gallstone Story: Pathogenesis and Epidemiology. Practical gastroenterology 2010; XXXIV.

67. The epidemiology of gallstone disease in Rome, Italy. Part I. Prevalence data in men. The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO). Hepatology 1988; 8: 904-6.

68. Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO). Prevalence of gallstone disease in an Italian adult female population. Am J Epidemiol 1984; 119: 796-805.

69. Attili AF, Capocaccia R, Carulli N, Festi D, Roda E, Barbara L, Capocaccia L, et al. Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis. Hepatology 1997; 26: 809-18.

70. Pazzi P, Gamberini S, Buldrini P, Gullini S. Biliary sludge: the sluggish gallbladder. Dig Liver Dis 2003; 35(Suppl. 3): S39-S45.

71. Davis M, Ryan JP. Influence of progesterone on guinea pig gallbladder motility in vitro. Dig Dis Sci 1986; 31: 513-8.

72. Gilat T, Konikoff F. Pregnancy and the biliary tract. Can J Gastroenterol 2000; 14(Suppl. D): 55D-59D.

73. Acalovschi M. Cholesterol gallstones: from epidemiology to prevention. Postgrad Med J 2001; 77: 221-9.

74. Cohen S. The sluggish gallbladder of pregnancy. N Engl J Med 1980; 302: 397-9.

75. Ko CW, Sekijima JH, Lee SP. Biliary sludge. Ann Intern Med 1999; 130: 301-11.

76. Sali A, Oats JN, Acton CM, Elzarka A, Vitetta L. Effect on pregnancy on gallstone formation. Aust N Z J Obstet Gynaecol 1989; 29: 386-9.

77. Kern F, Jr., Everson GT, DeMark B, McKinley C, Showalter R, Erfling W, Braverman DZ, et al. Biliary lipids, bile acids, and gallbladder function in the human female. Effects of pregnancy and the ovulatory cycle. J Clin Invest 1981; 68: 1229-42.

78. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997; 138: 863-70.

79. Iavarone M, Lampertico P, Seletti C, Francesca Donato M, Ronchi G, del Ninno E, Colombo M. The clinical and pathogenetic significance of estrogen receptor-beta expression in chronic liver diseases and liver carcinoma. Cancer 2003; 98: 529-34.

80. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC. Production and actions of estrogens. N Engl J Med 2002; 346: 340-52.

81. Coyne MJ, Bonorris GG, Chung A, Winchester R, Schoenfield LJ. Estrogen enhances dietary cholesterol induction of saturated bile in the hamster. Gastroenterology 1978; 75: 76-9.

82. Maclure KM, Hayes KC, Colditz GA, Stampfer MJ, Speizer FE, Willett WC. Weight, diet, and the risk of symptomatic gallstones in middle-aged women. N Engl J Med 1989; 321: 563-9.

83. Wang HH, Afdhal NH, Wang DQ. Overexpression of estrogen receptor alpha increases hepatic cholesterogenesis, leading to biliary hypersecretion in mice. J Lipid Res 2006; 47: 778-86.

84. Duan LP, Wang HH, Ohashi A, Wang DQ. Role of intestinal sterol transporters Abcg5, Abcg8, and Npc1l1 in cholesterol absorption in mice: gender and age effects. Am J Physiol 2006; 290: G269-G276.

85. Nervi FO, Del Pozo R, Covarrubias CF, Ronco BO. The effect of progesterone on the regulatory mechanisms of biliary cholesterol secretion in the rat. Hepatology 1983; 3: 360-7.

86. Down RH, Whiting MJ, Watts JM, Jones W. Effect of synthetic oestrogens and progestagens in oral contraceptives on bile lipid composition. Gut 1983; 24: 253-9.

87. Heuman DM, Hernandez CR, Hylemon PB, Kubaska WM, Hartman C, Vlahcevic ZR. Regulation of bile acid synthesis. I. Effects of conjugated ursodeoxycholate and cholate on bile acid synthesis in chronic bile fistula rat. Hepatology 1988; 8: 358-365.

88. Heuman DM, Vlahcevic ZR, Bailey ML, Hylemon PB. Regulation of bile acid synthesis. II. Effect of bile acid feeding on enzymes regulating hepatic cholesterol and bile acid synthesis in the rat. Hepatology 1988; 8: 892-7.

89. Shefer S, Nguyen L, Salen G, Batta AK, Brooker D, Zaki FG, Rani I, et al. Feedback regulation of bile-acid synthesis in the rat. Differing effects of taurocholate and tauroursocholate. J Clin Invest 1990; 85: 1191-8.

90. Stange EF, Scheibner J, Ditschuneit H. Role of primary and secondary bile acids as feedback inhibitors of bile acid synthesis in the rat in vivo. J Clin Invest 1989; 84: 173-80.

91. Wang DQ, Afdhal NH. Genetic analysis of cholesterol gallstone formation: searching for Lith (gallstone) genes. Curr Gastroenterol Rep 2004; 6: 140-50.

92. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet 2006; 368: 230-9.

93. Carey MC, Cahalane MJ. Whither biliary sludge? Gastroenterology 1988; 95: 508-23.

94. Ryan JP. Effect of pregnancy on gallbladder contractility in the guinea pig. Gastroenterology 1984; 87: 674-8.

95. Ryan JP. Calcium and gallbladder smooth muscle contraction in the guinea pig: effect of pregnancy. Gastroenterology 1985; 89: 1279-85.

96. Ryan JP, Pellecchia D. Effect of progesterone pretreatment on guinea pig gallbladder motility in vitro. Gastroenterology 1982; 83: 81-3.

97. Chen Q, Chitinavis V, Xiao Z, Yu P, Oh S, Biancani P, Behar J. Impaired G protein function in gallbladder muscle from progesterone-treated guinea pigs. Am J Physiol 1998; 274: G283-G289.

98. Newbern D, Freemark M. Placental hormones and the control of maternal metabolism and fetal growth. Curr Opin Endocrinol Diabetes Obes 2011; 18: 409-16.

99. Murphy VE, Smith R, Giles WB, Clifton VL. Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus. Endocr Rev 2006; 27: 141-69.

100. Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, Friedman JE. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 2007; 30(Suppl. 2): S112-S119.

101. Lain KY, Catalano PM. Metabolic changes in pregnancy. Clin Obstet Gynecol 2007; 50: 938-48.

102. Zavalza-Gomez AB, Anaya-Prado R, Rincon-Sanchez AR, Mora-Martinez JM. Adipokines and insulin resistance during pregnancy. Diabetes Res Clin Pract 2008; 80: 8-15.

103. Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol 2010; 63: 425-33.

104. Jamieson DJ, Theiler RN, Rasmussen SA. Emerging infections and pregnancy. Emerg Infect Dis 2006; 12: 1638-43.

105. Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, Backhed HK, Gonzalez A, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 2012; 150: 470-80.

106. Ko CW, Beresford SA, Schulte SJ, Lee SP. Insulin resistance and incident gallbladder disease in pregnancy. Clin Gastroenterol Hepatol 2008; 6: 76-81.

107. Collado MC, Isolauri E, Laitinen K, Salminen S. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr 2008; 88: 894-9.

108. Di Cianni G, Miccoli R, Volpe L, Lencioni C, Del Prato S. Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab Res Rev 2003; 19: 259-70.

109. Nelson SM, Matthews P, Poston L. Maternal metabolism and obesity: modifiable determinants of pregnancy outcome. Hum Reprod Update 2010; 16: 255-75.

110. Lawlor DA, Fraser A, Lindsay RS, Ness A, Dabelea D, Catalano P, Davey Smith G, et al. Association of existing diabetes, gestational diabetes and glycosuria in pregnancy with macrosomia and offspring body mass index, waist and fat mass in later childhood: findings from a prospective pregnancy cohort. Diabetologia 2010; 53: 89-97.

111. Menzies FM, Shepherd MC, Nibbs RJ, Nelson SM. The role of mast cells and their mediators in reproduction, pregnancy and labour. Hum Reprod Update 2011; 17: 383-96.

112. Catalano PM, Kirwan JP. Clinical utility and approaches for estimating insulin sensitivity in pregnancy. Semin Perinatol 2002; 26: 181-9.

113. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, Kalhan SC, et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 2002; 51: 2207-13.

114. Jumpertz R, Le DS, Turnbaugh PJ, Trinidad C, Bogardus C, Gordon JI, Krakoff J. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr 2011; 94: 58-65.

115. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444: 1022-3.

116. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-31.

117. Turnbaugh PJ, Gordon JI. The core gut microbiome, energy balance and obesity. J Physiol 2009; 587: 4153-8.

118. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004; 101: 15718-23.

119. Gielkens HA, Lam WF, Coenraad M, Frolich M, van Oostayen JA, Lamers CB, Masclee AA. Effect of insulin on basal and cholecystokinin-stimulated gallbladder motility in humans. J Hepatol 1998; 28: 595-602.

120. Haffner SM, Diehl AK, Mitchell BD, Stern MP, Hazuda HP. Increased prevalence of clinical gallbladder disease in subjects with non-insulin-dependent diabetes mellitus. Am J Epidemiol 1990; 132: 327-35.

121. Ruhl CE, Everhart JE. Association of diabetes, serum insulin, and C-peptide with gallbladder disease. Hepatology 2000; 31: 299-303.

122. Wu T, Zhang Z, Liu B, Hou D, Liang Y, Zhang J, Shi P. Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study. BMC Genomics 2013; 14: 669.

123. Sayin SI, Wahlstrom A, Felin J, Jantti S, Marschall HU, Bamberg K, Angelin B, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 2013; 17: 225-35.

124. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev 2010; 90: 859-904.

125. Diamant M, Blaak EE, de Vos WM. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obes Rev 2011; 12: 272-81.

126. Van Erpecum KJ, Van Berge-Henegouwen GP. Gallstones: an intestinal disease? Gut 1999; 44: 435-38.

127. Wang DQ, Cohen DE, Carey MC. Biliary lipids and cholesterol gallstone disease. J Lipid Res 2009; 50 (Suppl.): S406-S411.

128. Portincasa P, Ciaula AD, Bonfrate L, Wang DQ. Therapy of gallstone disease: What it was, what it is, what it will be. World J Gastrointest Pharmacol Ther 2012; 3: 7-20.

129. Maurer KJ, Ihrig MM, Rogers AB, Ng V, Bouchard G, Leonard MR, Carey MC, et al. Identification of cholelithogenic enterohepatic helicobacter species and their role in murine cholesterol gallstone formation. Gastroenterology 2005; 128: 1023-33.

130. Shaffer EA. Gallbladder sludge: what is its clinical significance? Curr Gastroenterol Rep 2001; 3: 166-73.

131. Filly RA, Allen B, Minton MJ, Bernhoft R, Way LW. In vitro investigation of the origin of echoes with biliary sludge. J Clin Ultrasound 1980; 8: 193-200.

132. Lee SP, Nicholls JF. Nature and composition of biliary sludge. Gastroenterology 1986; 90: 677-86.

133. Ko CW, Schulte SJ, Lee SP. Biliary sludge is formed by modification of hepatic bile by the gallbladder mucosa. Clin Gastroenterol Hepatol 2005; 3: 672-8.

134. Lee SP, Maher K, Nicholls JF. Origin and fate of biliary sludge. Gastroenterology 1988; 94: 170-6.

135. Strasberg SM. Cholelithiasis and acute cholecystitis. Baillieres Clin Gastroenterol 1997; 11: 643-61.

136. Jamidar PA, Beck GJ, Hoffman BJ, Lehman GA, Hawes RH, Agrawal RM, Ashok PS, et al. Endoscopic retrograde cholangiopancreatography in pregnancy. Am J Gastroenterol 1995; 90: 1263-7.

137. Tham TC, Vandervoort J, Wong RC, Montes H, Roston AD, Slivka A, Ferrari AP, et al. Safety of ERCP during pregnancy. Am J Gastroenterol 2003;98:308-11.

138. ACOG Committee on Obstetric Practice. ACOG Committee Opinion. Number 299, September 2004 (replaces No. 158, September 1995). Guidelines for diagnostic imaging during pregnancy. Obstet Gynecol 2004; 104: 647-51.

139. Barthel JS, Chowdhury T, Miedema BW. Endoscopic sphincterotomy for the treatment of gallstone pancreatitis during pregnancy. Surg Endosc 1998; 12: 394-9.

140. Sungler P, Heinerman PM, Steiner H, Waclawiczek HW, Holzinger J, Mayer F, Heuberger A, et al. Laparoscopic cholecystectomy and interventional endoscopy for gallstone complications during pregnancy. Surg Endosc 2000; 14: 267-71.

141. Kahaleh M, Hartwell GD, Arseneau KO, Pajewski TN, Mullick T, Isin G, Agarwal S, et al. Safety and efficacy of ERCP in pregnancy. Gastrointest Endosc 2004; 60: 287-92.

142. Ko C. Biliary sludge and acute pancreatitis during pregnancy. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 53-7.

143. Sharp HT. Gastrointestinal surgical conditions during pregnancy. Clin Obstet Gynecol 1994; 37: 306-15.

144. Angelico M, De Santis A, Capocaccia L. Biliary sludge: a critical update. J Clin Gastroenterol 1990; 12: 656-62.

145. Sitzmann JV, Pitt HA, Steinborn PA, Pasha ZR, Sanders RC. Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans. Surg Gynecol Obstet 1990; 170: 25-31.

146. Friedman JM, Little BB, Brent RL, Cordero JF, Hanson JW, Shepard TH. Potential human teratogenicity of frequently prescribed drugs. Obstet Gynecol 1990; 75: 594-9.

147. Glasgow RE, Visser BC, Harris HW, Patti MG, Kilpatrick SJ, Mulvihill SJ. Changing management of gallstone disease during pregnancy. Surg Endosc 1998; 12: 241-6.

148. Smoleniec JS, James DK. Gastro-intestinal crises during pregnancy. Dig Dis 1993; 11: 313-24.

149. Lu EJ, Curet MJ, El-Sayed YY, Kirkwood KS. Medical versus surgical management of biliary tract disease in pregnancy. Am J Surg 2004; 188: 755-9.

150. Dixon NP, Faddis DM, Silberman H. Aggressive management of cholecystitis during pregnancy. Am J Surg 1987; 154: 292-4.

151. Bellows CF, Berger DH, Crass RA. Management of gallstones. Am Fam Physician 2005; 72: 637-42.

152. Swisher SG, Schmit PJ, Hunt KK, Hiyama DT, Bennion RS, Swisher EM, Thompson JE. Biliary disease during pregnancy. Am J Surg 1994; 168: 576-9.

153. Cosenza CA, Saffari B, Jabbour N, Stain SC, Garry D, Parekh D, Selby RR. Surgical management of biliary gallstone disease during pregnancy. Am J Surg 1999; 178: 545-8.

154. Rollins MD, Chan KJ, Price RR. Laparoscopy for appendicitis and cholelithiasis during pregnancy: a new standard of care. Surg Endosc 2004; 18: 237-41.

155. McKellar DP, Anderson CT, Boynton CJ, Peoples JB. Cholecystectomy during pregnancy without fetal loss. Surg Gynecol Obstet 1992; 174: 465-8.

156. Lee SP, Nicholls JF, Park HZ. Biliary sludge as a cause of acute pancreatitis. N Engl J Med 1992; 326: 589-93.

157. Gouldman JW, Sticca RP, Rippon MB, McAlhany JC, Jr. Laparoscopic cholecystectomy in pregnancy. Am Surg 1998; 64: 93-7.

158. Lanzafame RJ. Laparoscopic cholecystectomy during pregnancy. Surgery 1995; 118: 627-31.

159. Robertson KW, Stewart IS, Imrie CW. Severe acute pancreatitis and pregnancy. Pancreatology 2006; 6: 309-15.

160. Affleck DG, Handrahan DL, Egger MJ, Price RR. The laparoscopic management of appendicitis and cholelithiasis during pregnancy. Am J Surg 1999; 178: 523-29.

161. Geisler JP, Rose SL, Mernitz CS, Warner JL, Hiett AK. Non-gynecologic laparoscopy in second and third trimester pregnancy: obstetric implications. JSLS 1998; 2: 235-8.

162. Stepp K, Falcone T. Laparoscopy in the second trimester of pregnancy. Obstet Gynecol Clin North Am 2004; 31: 485-96, vii.

163. Gurusamy KS, Koti R, Fusai G, Davidson BR. Early versus delayed laparoscopic cholecystectomy for uncomplicated biliary colic. Cochrane Database Syst Rev 2013; 6: CD007196.

164. Allmendinger N, Hallisey MJ, Ohki SK, Straub JJ. Percutaneous cholecystostomy treatment of acute cholecystitis in pregnancy. Obstet Gynecol 1995; 86: 653-4.

165. Mazzella G, Rizzo N, Azzaroli F, Simoni P, Bovicelli L, Miracolo A, Simonazzi G, et al. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers. Hepatology 2001; 33: 504-8.

166. Allen B, Bernhoft R, Blanckaert N, Svanvik J, Filly R, Gooding G, Way L. Sludge is calcium bilirubinate associated with bile stasis. Am J Surg 1981; 141: 51-6.

167. Glantz A, Reilly SJ, Benthin L, Lammert F, Mattsson LA, Marschall HU. Intrahepatic cholestasis of pregnancy: Amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine. Hepatology 2008; 47: 544-51.

168. Imam MH, Gossard AA, Sinakos E, Lindor KD. Pathogenesis and management of pruritus in cholestatic liver disease. J Gastroenterol Hepatol 2012; 27: 1150-8.

169. de Bari O, Neuschwander-Tetri BA, Liu M, Portincasa P, Wang DQ. Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic fatty liver disease. J Lipids 2012; 2012: 302847.

170. Ballantyne CM. Role of selective cholesterol absorption inhibition in the management of dyslipidemia. Curr Atheroscler Rep 2004; 6: 52-9.

171. Di Ciaula A, Wang DQ, Wang HH, Bonfrate L, Portincasa P. Targets for current pharmacologic therapy in cholesterol gallstone disease. Gastroenterol Clin North Am 2010; 39: 245-264, viii-ix.

172. Wang HH, Portincasa P, de Bari O, Liu KJ, Garruti G, Neuschwander-Tetri BA, Wang DQ. Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol. Eur J Clin Invest 2013; 43: 413-26.

173. Wang DQ, Tazuma S. Effect of beta-muricholic acid on the prevention and dissolution of cholesterol gallstones in C57L/J mice. J Lipid Res 2002; 43: 1960-8.

174. Broomfield PH, Chopra R, Sheinbaum RC, Bonorris GG, Silverman A, Schoenfield LJ, Marks JW. Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight. N Engl J Med 1988; 319: 1567-72.

175. Shiffman ML, Kaplan GD, Brinkman-Kaplan V, Vickers FF. Prophylaxis against gallstone formation with ursodeoxycholic acid in patients participating in a very-low-calorie diet program. Ann Intern Med 1995; 122: 899-905.

176. Worobetz LJ, Inglis FG, Shaffer EA. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss. Am J Gastroenterol 1993; 88: 1705-10.

177. Wang HH, Portincasa P, Mendez-Sanchez N, Uribe M, Wang DQ. Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones. Gastroenterology 2008; 134: 2101-10.

178. Lanzini A, Jazrawi RP, Kupfer RM, Maudgal DP, Joseph AE, Northfield TC. Gallstone recurrence after medical dissolution. An overestimated threat? J Hepatol 1986; 3: 241-6.

179. Rabenstein T, Radespiel-Troger M, Hopfner L, Benninger J, Farnbacher M, Greess H, Lenz M, et al. Ten years experience with piezoelectric extracorporeal shockwave lithotripsy of gallbladder stones. Eur J Gastroenterol Hepatol 2005; 17: 629-39.